CardioFocus today said its HeartLight X3 catheter ablation technology received approval from the Japanese Ministry of Health, Labor and Welfare. Marlborough, Mass.-based CardioFocus designed the catheter ablation technology for controlled and consistent pulmonary vein isolation to treat atrial fibrillation (AFib). Get the full story on our sister site, Medical Tubing + Extrusion.
Cardiovascular
Cleerly launches digital heart attack prevention software following $43M Series B
Cleerly today said it has launched its digital care software for heart attack prevention following a $43 million Series B funding round. New York–based Cleerly’s digital care technology is a non-invasive coronary computed tomography angiography that performs coronary artery phenotyping through artificial intelligence. According to the company, it uses millions of annotated lab images to […]
Medtronic wins expanded FDA approval for cryoablation catheters
Medtronic (NYSE:MDT) announced today that it received FDA expanded approval for its Arctic Front family of cardiac cryoablation catheters. Fridley, Minn.–based Medtronic’s Arctic Front family of catheters treat recurrent symptomatic paroxysmal atrial fibrillation (AFib) as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. Get the full story at our sister site, […]
VoluMetrix’s venous waveform monitor wins FDA breakthrough designation
VoluMetrix announced today that it received FDA breakthrough device designation for its NIVA HF venous waveform monitor. Nashville, Tenn.–based VoluMetrix designed the investigational NIVA HF device to monitor the venous waveform, a novel physiologic signal in heart failure patients, through its non-invasive venous waveform analysis (NIVA) technology. According to a news release, a fast-track grant […]
How Abbott engineered a catheter-delivered device for premature babies
Abbott’s experience designing its Piccolo device provides essential lessons for medical device creators who want to spark a pediatric medical device renaissance. The Amplatzer Piccolo occluder from Abbott is one of the first medical devices that health providers can implant in premature babies weighing as little as 2 lb to treat patent ductus arteriosus (PDA) […]
Martha sets 800 million patient mark for Medtronic
Can Medtronic really reach 10 times as many people as it does today? In an interview with MedtronicTalks, Geoff Martha says one year in the CEO seat has shown him the company is positioned to have a far greater impact on global health than it currently does. “We take great pride in that we impact […]
CVRx is going the IPO route
CVRx plans to hold an IPO to raise up to $75 million as it seeks to further commercialize its neuromodulation device to treat the heart. That’s according to a June 4 registration statement with the U.S. Securities and Exchange Commission that follows up on a registration confidentially filed with the SEC in April. The plan […]
Abbott wins CE mark for Amplatzer steerable delivery sheath
Abbott (NYSE:ABT) announced today that it received CE mark and Health Canada approval for its Amplatzer steerable delivery sheath. The company touts the Amplatzer sheath as the first steerable delivery sheath to be developed specifically for minimally invasive left atrial appendage (LAA) occlusion (or closure) procedures for patients diagnosed with atrial fibrillation who are at […]
7 startups grabbing the medtech spotlight in Minnesota
Minnesota has long been one of the nation’s top three medtech hubs and a good place for startups to get their footing. For 17 years, the MN Cup contest has offered cash prizes and the opportunity for medtech (and other) startups to tap into expert help to accelerate their businesses. MN Cup is a community-led, public-private partnership that […]
Philips touts 2-year data for Tack endovascular system
Royal Philips (NYSE:PHG) today announced positive two-year results from a clinical trial of the Tack endovascular system. Amsterdam-based Philips presented data from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial at the 2021 New Cardiovascular Horizons Conference, according to a news release. Data presented by co-principal investigator Dr. George Adams, an interventional […]
AliveCor purchases CardioLabs
Personal ECG tech company AliveCor is acquiring CardioLabs and its monitoring and cardiac diagnostic services. The financial terms of the deal were not disclosed in yesterday’s news release. “The acquisition of CardioLabs sets AliveCor on a course to becoming the premier provider of end-to-end cardiac diagnostic support,” AlilveCor CEO Priya Abani, said in the news […]
